MSICS Pharma
PrivateLast Round
Seed
May 6, 2026
Total Funding Raised
$7.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
MSICS Pharma is a biotechnology company developing medical-grade technology to grow and produce psilocybin for the treatment of mental health conditions such as PTSD, depression, and OCD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MSICS Pharma Comparables
Compare MSICS Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xentria, Inc. | 78% | |
| Kinevant Sciences | 77% | |
| SarcoMed USA | 76% | |
MSICS Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 6, 2026 | ||||
| Seed | Apr 5, 2026 |
MSICS Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FUSION | Seed |
| GlenRock Israel | Seed |
| SGL Acquisitions | Seed |
| L& Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
$3.6M round led by FUSION.
- Apr 5, 2026
$3.6M round led by GlenRock Israel, FUSION, and SGL Acquisitions.
MSICS Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MSICS Pharma's valuation, stock price, and market status.